TRCT
IMA

Tower Research Capital (TRC)’s ImageneBio Inc IMA Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.05K Buy
+1,011
New +$6.56K ﹤0.01% 4145
2025
Q4 		– Sell
-877
Closed -$7.15K – 5362
2025
Q3 		$7.15K Buy
877
+687
+362% +$9.11K ﹤0.01% 4114
2025
Q2 		$3.05K Buy
+190
New +$2.79K ﹤0.01% 4560
2025
Q1 		– Sell
-303
Closed -$5.96K – 5480
2024
Q4 		$5.96K Buy
303
+147
+94% +$2.97K ﹤0.01% 4219
2024
Q3 		$3.24K Sell
156
-1,522
-91% -$30.8K ﹤0.01% 4877
2024
Q2 		$33.2K Buy
1,678
+934
+126% +$16.5K ﹤0.01% 3409
2024
Q1 		$12.7K Buy
744
+328
+79% +$5.97K ﹤0.01% 3457
2023
Q4 		$9.84K Buy
416
+107
+35% +$3.49K ﹤0.01% 4339
2023
Q3 		$16.1K Buy
309
+233
+307% +$14K ﹤0.01% 3574
2023
Q2 		$6.01K Sell
76
-221
-74% -$15.8K ﹤0.01% 4752
2023
Q1 		$13K Sell
297
-863
-74% -$39.7K ﹤0.01% 3975
2022
Q4 		$37K Buy
1,160
+840
+263% +$26.8K ﹤0.01% 2565
2022
Q3 		$13K Buy
320
+56
+21% +$3.24K ﹤0.01% 4271
2022
Q2 		$14K Buy
264
+114
+76% +$6.29K ﹤0.01% 4141
2022
Q1 		$11K Buy
150
+4
+3% +$425 ﹤0.01% 4177
2021
Q4 		$22K Buy
146
+84
+135% +$13.6K ﹤0.01% 3563
2021
Q3 		$9K Sell
62
-40
-39% -$5.81K ﹤0.01% 4441
2021
Q2 		$17K Buy
+102
New +$22.5K ﹤0.01% 4043

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tower Research Capital (TRC)'s IMA Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in ImageneBio Inc (IMA) in Q1 2026: 1,011 shares worth $5.05K. The stake represents ﹤0.01% of the portfolio and ranks #4145 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in IMA as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in IMA in Q2 2021 and has held it in 18 quarters since. The position peaked at $37K in Q4 2022. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Tower Research Capital (TRC) held 1,011 shares of ImageneBio Inc worth $5.05K as of Q1 2026.
  • ImageneBio Inc was a new Tower Research Capital (TRC) position in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4145 holding.
  • Tower Research Capital (TRC) first reported a position in ImageneBio Inc in Q2 2021 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s ImageneBio Inc position peaked at $37K in Q4 2022.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.